Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

The roadmap calls for better research and funding to improve PCOS diagnosis, treatment, and health outcomes.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Topical finasteride's effectiveness for hair loss needs standardized evaluation methods.

Bicalutamide improved hair growth more than spironolactone in women with hair loss.

Alopecia areata treatments often don't lead to lasting improvement.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Abatacept may help some people with alopecia areata regrow hair.

The trial aims to test a new treatment for hair loss in young men using stem cell-derived vesicles.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

A trial found that using finasteride, a hair growth drug, can be effectively measured by comparing before and after photos.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

The study aims to find the most effective treatments for male pattern baldness.

Finasteride effectively reduces the need for surgery and urinary issues in men with BPH over the long term.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Tofacitinib may help treat severe hair loss, but more research is needed.